Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48,041,653
-
Number of holders
-
188
-
Total 13F shares, excl. options
-
47,668,681
-
Shares change
-
+945,161
-
Total reported value, excl. options
-
$1,088,709,499
-
Value change
-
+$20,128,588
-
Put/Call ratio
-
7296%
-
Number of buys
-
87
-
Number of sells
-
-79
-
Price
-
$22.84
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q1 2025
211 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q1 2025.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 188 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,668,681 shares
of 48,041,653 outstanding shares and own 99% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (8,707,165 shares), BlackRock, Inc. (5,472,493 shares), Invesco Ltd. (3,551,054 shares), VANGUARD GROUP INC (2,804,140 shares), FRED ALGER MANAGEMENT, LLC (1,533,122 shares), STATE STREET CORP (1,433,796 shares), T. Rowe Price Investment Management, Inc. (1,348,008 shares), AMERIPRISE FINANCIAL INC (970,412 shares), Rockefeller Capital Management L.P. (964,257 shares), and PALISADE CAPITAL MANAGEMENT, LP (947,085 shares).
This table shows the top 188 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.